Student society wins the biggest consulting competition in the UK
Imperial Global Singapore celebrates a year of research collaboration and impact
NHS staff take first steps towards research careers
Harnessing the healing mechanisms in our body to deliver new targeted therapies
Project 1 focuses on engineered molecules that contain ADP-ribose
Learn more
Project 2 looks at exploiting the healing properties of engineered extra-cellular vesicles from cells
Project 3 centres on the use of ionic liquids and deep eutectic solvents in pharmaceuticals
The Engineered Medicines Laboratory (EML) is a unique collaboration between the global healthcare company GlaxoSmithKline (GSK) and Imperial College that aims to develop transformative advances in the discovery, development and manufacturing of future medicines.
Find Out More
The global healthcare company GlaxoSmithKline endeavours to improve people's health and well-being throughout the world by researching and developing medicines, vaccines and consumer healthcare products.
Find out more
EML adopts an innovative and unique approach to pharmaceutical research and the development of medicines in the UK. The long-running collaboration with GSK strives to push these technological advances into wider society.
